Foundation / Corporation
Grants of up to $80,000 a year to USA IHEs to support fellowship programs relevant to research on inflammatory and immune-mediated skin diseases. Funding is to be used to supplement the salary of a fellow at the organization. Priority will be given to the organizations that provide training and guidance to the fellow. Of interest to the funding source are programs that focus on clinical practice, research, and education to further the understanding of inflammatory skin diseases.
The intent of this Request for Proposal (RFP) is to encourage organizations with an active fellowship program relevant to inflammatory and immune-mediated skin diseases fellowship program to submit a proposal. The purpose of the Fellowship Program grant is to provide support for the continued training of fellows in any year of a program focused on research. Organizations seeking funding must submit proposals describing the strength of their program in supporting clinical training and research.
The Pfizer Fellowship Program (“Fellowship Program”) is a reflection of Pfizer’s commitment to advancing research, innovation, clinical expertise and medical education for medical, nursing, and allied health professionals. This program provides career-building opportunities for practicing clinicians and academic researchers in outcomes and patient-oriented research that is vital to improving healthcare.
The mission of Pfizer Independent Grants for Learning & Change (IGLC) is to partner with the global healthcare community to improve patient outcomes in areas of mutual interest through support of measurable learning and change strategies. “Independent” means that the projects funded by Pfizer are the full responsibility of the recipient organization. Pfizer has no influence over any aspect of the projects and only asks for reports about the results and the impact of the projects in order to share them publicly.-
Funding will be awarded to the organization, which will select the recipient. Funding must be used primarily as salary and fringe support for the selected fellow, not for overhead or indirect costs.
Requirements for Research Projects:
This grant opportunity is to support fellows involved with independent research that seeks to improve the organization, financing and/or delivery of strategies and initiatives that promote health and prevent disease and disability in patients with inflammatory and immune-mediated skin diseases. Examples of such research include, but are not limited to: observational studies and outcomes research studies where the primary focus is the scientific understanding of disease; novel approaches to implementing improvements in practice; use of screening tools and their impact on improvement of patient health.
GrantWatch ID#: 183296
Up to $80,000 per year for up to two years
Program start date must be after June 1, 2018. Fellowships funded in 2018 must be completed before December 31, 2019.
The following requirements are in place for the Fellowship:
- Application must be submitted by an accredited U.S.-based academic organization.
- The organization cannot host more than one (1) fellow funded through this same award during the proposed term.
- Senior staff, division heads, or department chairs should work on behalf of their organization to prepare and submit an application for consideration.
- Do not include the name of the potential fellow in application materials. This is an organizational grant and the attributes of an individual fellow will not be taken into consideration.
Requirements for Prospective Fellows:
- Prospective award recipients at the organization cannot apply directly for the award. However, a fellow may assist the senior staff, division head, or department chair at the organization in the development of the application.
- Fellows supported by a Pfizer fellowship must have the opportunity to carry out supervised research with the primary objective preparation for their respective discipline and subspecialty.
- Upon receipt of the award, the fellow selected by the organization must meet the following criteria: U.S. citizen or foreign national with permanent U.S.residence who holds an advanced degree (e.g., PhD, MD, DO, NP, PharmD, etc.
Examples of research that would be ineligible include research involving the study and/or evaluation of any pharmaceutical product and basic science and/or fundamental research (in animal model, in-vitro, etc.).
Funding from Pfizer IGLC cannot be used towards food or beverages for learners/participants in any way or for
This grant opportunity does not commit Pfizer to award a grant nor to pay any costs incurred in the preparation of a response to this RFP or any other expenses.
U.S. Physician Payments Sunshine Act (“Sunshine Act”) and other transparency law reporting requirements must be satisfied with respect to meals, payments, travel and other transfers of value. Please note, if applicable, the selected fellow will be named in transparency reporting as a recipient of grant funding.
Applications due date: March 30, 2018
Decision Notification date: May 25, 2018
All applicants will be notified via email by the dates noted above. Applicants may be asked for additional clarification during the review process.
Be advised applications submitted through the wrong application type and/or submitted after the due date will not be reviewed by the committee.
Before starting your grant application, please review the funding source's website listed below for updates/changes/addendums/conferences/LOIs.
To register, please go to http://www.cybergrants.com/pfizer/IGLCfellowship
Enter Invitation Code: 8924XKZ2B9 (expires 3/30/2018)
If you have questions regarding this grant opportunity or the Fellowship program, please contact email@example.com, with the subject line “Inflammatory and Immune-mediated Skin Diseases Fellowship 2018.”
235 East 42nd Street NY, NY 10017
USA: Alabama; Alaska; Arizona; Arkansas; California; Colorado; Connecticut; Delaware; Florida; Georgia; Hawaii; Idaho; Illinois; Indiana; Iowa; Kansas; Kentucky; Louisiana; Maine; Maryland; Massachusetts; Michigan; Minnesota; Mississippi; Missouri; Montana; Nebraska; Nevada; New Hampshire; New Jersey; New Mexico; New York City; New York; North Carolina; North Dakota; Ohio; Oklahoma; Oregon; Pennsylvania; Rhode Island; South Carolina; South Dakota; Tennessee; Texas; Utah; Vermont; Virginia; Washington, DC; Washington; West Virginia; Wisconsin; Wyoming